L-Carnitine inner salt
Type 2 diabetes mellitus (T2DM) and AD share metabolic abnormalities, including insulin resistance, mitochondrial dysfunction, inflammation, and increased oxidative stress
Without a robust pre-authorization process, these behaviours can multiply quickly especially when members realize the drugs are covered
Its oral bioavailability is achieved by incorporating the absorption enhancer SNAC (Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate), which works through two mechanisms: (1) temporarily raising the local pH in the stomach to reduce pepsin-induced degradation of the peptide drug, and (2) forming hydrophobic ion pairs (HIP) with the peptide drug, improving its membrane permeability
10.1007/s40279-015-0379-7 139 Iturria-MedinaY.SoteroR
To Issue 160 C itation: Giacon M, Gordon J, Delivering on GLP-1 Demand: a Combination of Device Offerings and Supply Strategy